Evaluation of genetic variants in nucleosome remodeling and deacetylase (NuRD) complex subunits encoding genes and gastric cancer susceptibility

[1]  Yi-wu Shi,et al.  CHD4 variants are associated with childhood idiopathic epilepsy with sinus arrhythmia , 2021, CNS neuroscience & therapeutics.

[2]  Dali Li,et al.  GATA zinc finger domain‐containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with β‐thalassaemia through impaired formation of methyl‐binding domain protein 2 (MBD2)‐containing nucleosome remodelling and deacetylation (NuRD) complex , 2021, British journal of haematology.

[3]  Chun‐Chieh Wu,et al.  CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer , 2021, International journal of biological sciences.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  W. Gong,et al.  Genetic variants in m6A regulators are associated with gastric cancer risk , 2021, Archives of Toxicology.

[6]  Qiulian Wu,et al.  FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells , 2020, Cell.

[7]  P. Sullivan,et al.  A shared genetic contribution to breast cancer and schizophrenia , 2020, Nature Communications.

[8]  W. Scheithauer,et al.  Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial. , 2020, European journal of cancer.

[9]  Yijie Wang,et al.  CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors , 2020, Cancer Research.

[10]  P. Cramer,et al.  Nucleosome-CHD4 chromatin remodeler structure maps human disease mutations , 2020, eLife.

[11]  Hongbing Shen,et al.  Remote modulation of lncRNA GCLET by risk variant at 16p13 underlying genetic susceptibility to gastric cancer , 2020, Science Advances.

[12]  Runsheng Chen,et al.  LncRNA HRCEG, regulated by HDAC1, inhibits cells proliferation and epithelial-mesenchymal-transition in gastric cancer. , 2020, Cancer genetics.

[13]  F. Jardin,et al.  A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC network study. , 2019, Neuro-oncology.

[14]  C. Romier,et al.  Citrullination of pyruvate kinase M2 by PADI1 and PADI3 regulates glycolysis and cancer cell proliferation , 2019, Nature Communications.

[15]  Wei Chen,et al.  Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis , 2019, Journal of Experimental & Clinical Cancer Research.

[16]  C. Verrijzer,et al.  Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer , 2019, Genes & development.

[17]  Hongbing Shen,et al.  Combinations of single nucleotide polymorphisms identified in genome‐wide association studies determine risk for colorectal cancer , 2019, International journal of cancer.

[18]  Tian-qi Wang,et al.  Role of HDAC1 in the progression of gastric cancer and the correlation with lncRNAs , 2019, Oncology letters.

[19]  Prashanth Rawla,et al.  Epidemiology of gastric cancer: global trends, risk factors and prevention , 2018, Przeglad gastroenterologiczny.

[20]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[21]  Paul Bertone,et al.  The Nucleosome Remodeling and Deacetylation Complex Modulates Chromatin Structure at Sites of Active Transcription to Fine-Tune Gene Expression , 2018, Molecular cell.

[22]  F. Conlon,et al.  CHD4 and the NuRD complex directly control cardiac sarcomere formation , 2018, Proceedings of the National Academy of Sciences.

[23]  T. Kawaguchi,et al.  Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers , 2018, PloS one.

[24]  B. Guo,et al.  Knockdown of GATAD2A suppresses cell proliferation in thyroid cancer in vitro. , 2017, Oncology reports.

[25]  J. Rosenfeld,et al.  De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms. , 2016, American journal of human genetics.

[26]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[27]  P. Zhang,et al.  Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours , 2015, Gut.

[28]  G. Blobel,et al.  The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex. , 2015, The Biochemical journal.

[29]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[30]  田原 康玄,et al.  生活習慣病とgenome-wide association study , 2015 .

[31]  B. Klaholz,et al.  Structure and function insights into the NuRD chromatin remodeling complex , 2015, Cellular and Molecular Life Sciences.

[32]  M. Muramatsu,et al.  Association of the chromodomain helicase DNA‐binding protein 4 (CHD4) missense variation p.D140E with cancer: Potential interaction with smoking , 2015, Genes, chromosomes & cancer.

[33]  M. Plummer,et al.  Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.

[34]  P. Hou,et al.  Pathogenetic mechanisms in gastric cancer. , 2014, World journal of gastroenterology.

[35]  H. Zhang,et al.  The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction Adenocarcinoma , 2013, PloS one.

[36]  R. Burbano,et al.  DNA and histone methylation in gastric carcinogenesis. , 2013, World journal of gastroenterology.

[37]  R. Burbano,et al.  Epigenetic mechanisms in gastric cancer. , 2012, Epigenomics.

[38]  H. Stunnenberg,et al.  CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex. , 2010, Molecular bioSystems.

[39]  Carlos Resende,et al.  Genetic and Epigenetic Alteration in Gastric Carcinogenesis , 2010, Helicobacter.

[40]  N. Hu,et al.  A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma , 2010, Nature Genetics.

[41]  Wei Xie,et al.  A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma , 2010, BMC medicine.

[42]  M. Toyota,et al.  Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling. , 2009, Gastroenterology.

[43]  Luyang Sun,et al.  LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer , 2009, Cell.

[44]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[45]  Yan-shen Peng,et al.  The Expression and Clinical Significance of DNA Methyltransferase Proteins in Human Gastric Cancer , 2008, Digestive Diseases and Sciences.

[46]  藤兼 智子,et al.  Metastasis-associated gene , 2007 .

[47]  J. Leers,et al.  p66α and p66β of the Mi-2/NuRD complex mediate MBD2 and histone interaction , 2006, Nucleic acids research.

[48]  N. Ahmed.  23 years of the discovery of Helicobacter pylori: Is the debate over? , 2005, Annals of Clinical Microbiology and Antimicrobials.

[49]  R. Renkawitz,et al.  Two Highly Related p66 Proteins Comprise a New Family of Potent Transcriptional Repressors Interacting with MBD2 and MBD3* , 2002, The Journal of Biological Chemistry.

[50]  Andre Scedrov,et al.  Functional polymorphism , 1990 .

[51]  M. Rauchman,et al.  The nucleosome remodeling and deacetylase complex in development and disease. , 2015, Translational research : the journal of laboratory and clinical medicine.

[52]  H. Stunnenberg,et al.  CDK 2 AP 1 / DOC-1 is a bona fide subunit of the Mi-2 / NuRD complex w z , 2010 .